| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/06/2009 | CN101422486A Velvet antler insulin active factor extraction method |
| 05/06/2009 | CN101422471A Use of prunol glycoside and plant extract containing the same |
| 05/06/2009 | CN101422465A Use of ursolic acid and plant extract containing the same |
| 05/06/2009 | CN101422452A Use of rosmarinic acid and plant extract containing rosmarinic acid |
| 05/06/2009 | CN101422450A Cajanus cajan L. natural medicine with blood sugar reduction and weight reduction function |
| 05/06/2009 | CN101422446A Vitamin K micro-capsule preparation method |
| 05/06/2009 | CN101422443A Fenofibrate osmotic pump controlled release preparation and preparation method thereof |
| 05/06/2009 | CN101422431A Insulation administration preparation through nose |
| 05/06/2009 | CN100485035C Novel scavenger albumen receptors |
| 05/06/2009 | CN100484934C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 05/06/2009 | CN100484933C Novel pyrazine compounds, their use in preparing medicament for treating diseases correlated with serotonin |
| 05/06/2009 | CN100484555C Application of Aloe vera L. extract in preparing medicament and health products for preventing and curing diabetes |
| 05/06/2009 | CN100484552C Health protection capsule |
| 05/06/2009 | CN100484539C Functional food with blood sugar reducing action and its preparing method |
| 05/06/2009 | CN100484517C Smash-resisting panax notoginseng total saponin free-dried powdery injection and its preparation |
| 05/06/2009 | CN100484408C A fat-reducing health tea and preparation method thereof |
| 05/06/2009 | CN100484400C Diphenylethylene compound |
| 05/05/2009 | US7528265 Process for the preparation of simvastatin |
| 05/05/2009 | US7528162 such as 3-(4-Chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-N-(piperidin-1-yl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine, used as cannabinoid (CB1) receptor antagonists, for prophylaxis of psychological disorders |
| 05/05/2009 | US7528160 {6-[5-Methyl-2-(4-trifluoromethyl-phenyl)-oxazol-4-ylmethoxy]-benzo[b]thiophen-3-yl}-acetic acid; antidiabetic agent; metabolic Syndrome, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; lowering fibrinogen, increasing HDL levels |
| 05/05/2009 | US7528154 Polyarylcarboxamides useful as lipid lowering agents |
| 05/05/2009 | US7528140 Substituted pyrrolo[3,2-d]pyrimidines as glycogen synthase kinase (GSK) inhibitors |
| 05/05/2009 | US7528124 1,3-dihydro-2H-indol-2-one derivative |
| 05/05/2009 | US7527974 Preparing embryonic stem cells via nuclear transplantation; tissue engineering and the use of embryonic stem in diagnosis, prevention and treatment of cell proliferative, nervous system, muscular and bone disorders; tissue repair |
| 05/05/2009 | US7527790 Genetic engineered protein; screening, controlling gene expression |
| 05/05/2009 | CA2622696A1 Methods and compositions for retarding weight gain associated with use of atypical antipsychotic drugs |
| 05/05/2009 | CA2448281C Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors |
| 05/05/2009 | CA2391440C Process for enhancing canine and feline reproductive performance |
| 05/05/2009 | CA2309818C Buffered drug formulations for transdermal electrotransport delivery |
| 04/30/2009 | WO2009055783A2 Anti-pcsk9 and methods for treating lipid and cholesterol disorders |
| 04/30/2009 | WO2009055331A2 Bicyclic heterocycle derivatives and their use as modulators of the activity of gpr119 |
| 04/30/2009 | WO2009054994A2 Use of compounds activating sirt-3 for mimicking exercise |
| 04/30/2009 | WO2009054693A2 Process for the preparation of atorvastatin |
| 04/30/2009 | WO2009054682A2 Prodrug of atrovastatin by cholesterol's synthesis inhibitors |
| 04/30/2009 | WO2009054504A1 Ligand agent for peroxisome proliferator-activated receptor (ppar) |
| 04/30/2009 | WO2009054483A1 Drug containing salusin-β |
| 04/30/2009 | WO2009054479A1 Spiro-ring compound and use thereof for medical purposes |
| 04/30/2009 | WO2009054458A1 Composition for reducing the level of glucose, malondialdehyde-modified ldl, homocysteine and/or c-reactive protein in blood |
| 04/30/2009 | WO2009054434A1 Amine derivative having npy y5 receptor antagonist activity and use thereof |
| 04/30/2009 | WO2009054423A1 Oxadiazolidinedione compound |
| 04/30/2009 | WO2009054390A1 Thiazolidinedione compound |
| 04/30/2009 | WO2009054360A1 Agent for specifically reducing visceral fat |
| 04/30/2009 | WO2009053799A1 Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation |
| 04/30/2009 | WO2009053794A2 The use of a monocyclic monoterpene in manufacturing medicaments for treatment of diabetes |
| 04/30/2009 | WO2009053793A2 Use of volatile oil from plants in preparing medicaments for preventing and treating diabetes |
| 04/30/2009 | WO2009053725A2 Peptides and uses thereof |
| 04/30/2009 | WO2009053716A1 Purine derivatives useful as pi3 kinase inhibitors |
| 04/30/2009 | WO2009053652A2 Pharmaceutical or dietetic composition comprising an aqueous extract of nigella sativa |
| 04/30/2009 | WO2009053487A2 Proteins that stimulate the secretion of satiety hormones |
| 04/30/2009 | WO2009033733A3 Use of apeptide as a therapeutic agent |
| 04/30/2009 | WO2009015037A3 5-pyridinone substituted indazoles |
| 04/30/2009 | WO2004092199A3 Method for identifying modulators of g protein coupled receptor signaling |
| 04/30/2009 | US20090111893 Method of lowering blood glucose and method of preventing or treating blood glucose and method of preventing or treating diabetes and obesity |
| 04/30/2009 | US20090111879 Administering N-(2,6-Dichlorobenzoyl)-4-(2,6-dimethoxy-4-methoxymethylphenyl)-L-phenylalanine ethyl ester for therapy of asthma, inflammatory bowel disease, rheumatoid arthritis and atopic dermatitis |
| 04/30/2009 | US20090111877 Methods for Enhancing the Quality of Life of a Senior Animal |
| 04/30/2009 | US20090111876 Extracts from chlorella |
| 04/30/2009 | US20090111859 2-(5,5-Dimethylcyclopent-1-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane; metabolic disorders such as type II diabetes |
| 04/30/2009 | US20090111855 SUBSTITUTED PHENOXY THIAZOLIDINEDIONES AS ESTROGEN RELATED RECEPTOR-alpha MODULATORS |
| 04/30/2009 | US20090111813 Dialkylamino alkyl esters of pivagabine as medicaments for the treatment of central nervous system disorders |
| 04/30/2009 | US20090111812 Methods for treating inflammatory disorders |
| 04/30/2009 | US20090111809 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 04/30/2009 | US20090111807 Novel 1,2,3,4-Tetrahydroquinoxaline Derivative Having Glucocorticoid Receptor Binding Activity |
| 04/30/2009 | US20090111791 Soluble Epoxide Hydrolase Inhibitors and Methods of Using Same |
| 04/30/2009 | US20090111790 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 04/30/2009 | US20090111778 2-Keto-Oxazoles as Modulators of Fatty Acid Amide Hydrolase |
| 04/30/2009 | US20090111777 Jelly Composition |
| 04/30/2009 | US20090111771 Inhibition of cathepsin k activity and the treatment and prevention of disease |
| 04/30/2009 | US20090111765 Compositions and methods for immunostimulatory rna oligonucleotides |
| 04/30/2009 | US20090111752 Stable Formulation of Modified GLP-1 |
| 04/30/2009 | US20090111744 Human Growth Gene and Short Stature Gene Region |
| 04/30/2009 | US20090111730 Polypeptide protracting tags |
| 04/30/2009 | US20090110760 Lipometabolism improver containing pine bark extract |
| 04/30/2009 | US20090110758 Compositions and methods for promoting weight loss |
| 04/30/2009 | US20090110752 Composition for controlling blood glucose and method thereof |
| 04/30/2009 | US20090110742 Long-acting colloidal insulin formulation and its preparation |
| 04/30/2009 | US20090110740 Materials and Methods for Modulating Metabolism |
| 04/30/2009 | US20090110677 Polypeptide regulating phosphate metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same |
| 04/30/2009 | US20090110664 Probiotic compositions and methods for inducing and supporting weight loss |
| 04/30/2009 | US20090110661 Novel Gene Therapy Approach For Treating The Metabolic Disorder Obesity |
| 04/30/2009 | US20090110647 Method of preventing adverse effects by glp-1 |
| 04/30/2009 | DE102008022102A1 Zusammensetzung zum Regulieren von Glucose im Blut und dazugehöriges Verfahren Composition for regulating glucose in the blood and associated method |
| 04/30/2009 | DE102007051339A1 Use of an aliphatic or aromatic hydrocarbon compound for manufacturing a preparation to prevent or treat dyslipidemia |
| 04/30/2009 | DE102007051338A1 Use of substituted glycerin derivatives for producing pharmaceutical preparation to prevent or treat isolated and/or combined dyslipidemia, hypertriglyceridemia and/or hypercholesterolemia, and for treating e.g. Parkinson's disease |
| 04/30/2009 | CA2704013A1 Spiro-ring compound and use thereof for medical purposes |
| 04/30/2009 | CA2703797A1 Amine derivative having npy y5 receptor antagonist activity and use thereof |
| 04/30/2009 | CA2703793A1 Oxadiazolidinedione compound |
| 04/30/2009 | CA2703712A1 Anti-pcsk9 and methods for treating lipid and cholesterol disorders |
| 04/30/2009 | CA2703645A1 Composition for reducing the level of glucose, malondialdehyde-modified ldl, homocysteine and/or c-reactive protein in blood |
| 04/30/2009 | CA2703203A1 Bicyclic heterocycle derivatives and methods of use thereof |
| 04/30/2009 | CA2703138A1 Purine derivatives useful as pi3 kinase inhibitors |
| 04/29/2009 | EP2053409A1 Specific markers for metabolic syndrome |
| 04/29/2009 | EP2052734A1 Proteins that stimulate the secretion of satiety hormones |
| 04/29/2009 | EP2052729A1 Antiobesity composition containing component originating in the bark of tree belonging to the genus acacia |
| 04/29/2009 | EP2052728A1 Hypoglycemic composition containing component originating in the bark of tree belonging to the genus acacia |
| 04/29/2009 | EP2052727A2 Hoodia extract oil compositions comprising unsaturated monoacylglycerides |
| 04/29/2009 | EP2051979A2 Polymorphic forms of rosiglitazone base |
| 04/29/2009 | EP2051977A2 SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLbeta-HSD-1 |
| 04/29/2009 | EP2051732A1 Methods of diagnosis and treatment for metabolic disorders |
| 04/29/2009 | EP2051725A1 Methods of treating obesity using satiety factors |
| 04/29/2009 | EP2051723A1 Processes for production of hoodia plant extracts containing steroidal glycosides |